Score Overview
Explore the 2021 public Archive ranking →
Where Biomerica Inc has ranked, year by year
Showing 5 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- BMRA
2011: 89.2% · 2021: 85.7% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-30 | $ 2.26 | — |
1 Year2025-09-30 | $ 2.83 | -20.14% |
5 Years2021-09-30 | $ 36.00 | -93.72% |
10 Years2016-09-30 | $ 20.88 | -89.18% |
20 Years2006-09-29 | $ 4.16 | -45.67% |
30 Years1996-09-30 | $ 37.00 | -93.89% |
All Time2005-01-03 | $ 3.20 | -29.38% |
| Period | Last Price2026-09-30 | 1 Year2025-09-30 | 5 Years2021-09-30 | 10 Years2016-09-30 | 20 Years2006-09-29 | 30 Years1996-09-30 | All Time2005-01-03 |
|---|---|---|---|---|---|---|---|
| Price | $ 2.26 | $ 2.83 | $ 36.00 | $ 20.88 | $ 4.16 | $ 37.00 | $ 3.20 |
| Return | — | -20.14% | -93.72% | -89.18% | -45.67% | -93.89% | -29.38% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| 2026 | $ 4M | -$ 3M | $ 1M |
| 2025 | $ 5M | -$ 4M | $ 2M |
| 2024 | $ 5M | -$ 5M | $ 4M |
| 2023 | $ 5M | -$ 7M | $ 9M |
| 2022 | $ 18M | -$ 4M | $ 5M |
| 2021 | $ 7M | -$ 7M | $ 4M |
| 2020 | $ 6M | -$ 2M | $ 8M |
| 2019 | $ 5M | -$ 2M | $ 686.78K |
| 2018 | $ 5M | -$ 1M | $ 1M |
| 2017 | $ 5M | -$ 908.56K | $ 1M |
| 2016 | $ 5M | -$ 1M | $ 1M |
| 2015 | $ 4M | -$ 331.41K | $ 1M |
| 2014 | $ 5M | -$ 215.66K | $ 1M |
| 2013 | $ 6M | $ 536.96K | $ 2M |
| 2012 | $ 6M | $ 548.43K | $ 1M |
| 2011 | $ 4M | $ 157.45K | $ 989.27K |
| 2010 | $ 5M | -$ 331.45K | $ 1M |
| 2009 | $ 4M | $ 354.18K | $ 1M |
| 2008 | $ 4M | $ 1M | $ 2M |
| 2007 | $ 5M | $ 536.88K | $ 517.43K |
| 2006 | $ 7M | $ 230.27K | $ 123.19K |
| IPO2005 | $ 9M | $ 162.26K | $ 360.06K |
Biomerica Inc fundamental performance
Between 2021 and 2026, revenue declined from $ 7M to $ 4M and net income went from -$ 7M to -$ 3M. Revenue increased in 2 of those 5 years; net income in 4.
Between 2016 and 2026, revenue declined from $ 5M to $ 4M and net income went from -$ 1M to -$ 3M. Revenue increased in 5 of those 10 years; net income in 6.
Biomerica Inc currently holds a 20-year HDB Score of 2.1 out of 10. How the HDB Score is calculated.
Membership
Continue BMRA’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
